@article{7d1b8205f05145db94b9e3ffafc72eab,
title = "Genomic profiling of high-intermediate risk endometrial cancer to differentiate recurrence risk.",
author = "Dobbin, \{Zachary Christopher\} and Landers, \{Emily E.\} and Londono, \{Angelina I\} and Katre, \{Ashwini A.\} and Yang, \{Eddy Shih-Hsin\} and Boone, \{Jonathan David\} and Bevis, \{Kerri S.\} and Straughn, \{John Michael\} and Huh, \{Warner King\} and Leath, \{Charles A.\} and David Crossman and Alvarez, \{Ronald David\} and Arend, \{Rebecca Christian\}",
note = "e17103 Background: While the majority of patients diagnosed with endometrial cancer (EMCA) have low-risk disease at the time of diagnosis, a subset of patients with Stage I disease are classified as high-intermediate risk (H-IR) based on pathologic risk factors. H-IR EMCA patients have a 30\% risk of recurrence.",
year = "2016",
month = may,
day = "20",
doi = "10.1200/JCO.2016.34.15\_SUPPL.E17103",
language = "American English",
volume = "34",
journal = "Journal of Clinical Oncology",
}